- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Institutional Culture and Sensitive Investigations
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Brandt Leibe
Insights 28 results
Client Alert
April 18, 2025
Drug Cartel Designations as FTOs Increase Financial Institutions’ Civil Liability Risks Under the Antiterrorism Act
Client Alert
March 31, 2025
Recent FTO Designations Raise FCA Liability Concerns for Multinational Organizations
Article · Source: Law360
March 26, 2025
Include State And Local Enforcers In Cartel Risk Evaluations
Client Alert
March 11, 2025
Recent Decisions and DOJ Policy Announcements Signal Key Changes to FCA Enforcement and Litigation Environment
Client Alert
Article · Source: CPO Magazine
March 5, 2025
DOJ Continues Cybersecurity False Claims Act Enforcement in New Administration
Article · Source: Global Investigations Review
February 28, 2025
How does the Trump FCPA pause change the landscape for non-American companies?
Article · Source: Global Investigations Review Guide to Multilateral Development Bank Investigations
February 27, 2025
Maintaining Business Integrity: The Private Practice Perspective
Client Alert
February 24, 2025
DOJ Continues Cybersecurity False Claims Act Enforcement in New Administration
Article · Source: Law360
January 13, 2025
Preparing For Mexican Drug Cartels' Terrorist Designation
Article · Source: Mondaq
October 14, 2024
United States District Court in Florida Holds False Claims Act Qui Tam Provision Unconstitutional
Client Alert
October 10, 2024
United States District Court in Florida Holds False Claims Act Qui Tam Provision Unconstitutional